Immunotolerant Properties of Mesenchymal Stem Cells: Updated Review
- PMID: 26839557
- PMCID: PMC4709780
- DOI: 10.1155/2016/1859567
Immunotolerant Properties of Mesenchymal Stem Cells: Updated Review
Abstract
Stem cell transplantation is a potential therapeutic option to regenerate damaged myocardium and restore function after infarct. Current research is focused on the use of allogeneic mesenchymal stem cells (MSCs) due to their unique immunomodulatory characteristics and ability to be harvested from young and healthy donors. Both animal and human studies support the immunoprivileged state of MSCs and even demonstrate improvements in cardiac function after transplantation. This research continues to be a topic of interest, as advances will ultimately enable the clinical use of these universal cells for therapy after a myocardial infarction. Updated in vitro, in vivo, and clinical trial studies are discussed in detail in the following review.
Similar articles
-
C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.J Card Fail. 2017 May;23(5):403-415. doi: 10.1016/j.cardfail.2017.03.002. Epub 2017 Mar 8. J Card Fail. 2017. PMID: 28284757
-
Role of interleukin-7 in fusion of rat bone marrow mesenchymal stem cells with cardiomyocytes in vitro and improvement of cardiac function in vivo.Cardiovasc Ther. 2018 Dec;36(6):e12479. doi: 10.1111/1755-5922.12479. Epub 2018 Dec 6. Cardiovasc Ther. 2018. PMID: 30451388
-
MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart.J Cardiovasc Pharmacol. 2015 Mar;65(3):241-51. doi: 10.1097/FJC.0000000000000183. J Cardiovasc Pharmacol. 2015. PMID: 25658461 Free PMC article.
-
Therapeutic use of stem cells for cardiovascular disease.Clin Transl Med. 2016 Dec;5(1):34. doi: 10.1186/s40169-016-0116-3. Epub 2016 Aug 18. Clin Transl Med. 2016. PMID: 27539581 Free PMC article. Review.
-
[Mesenchymal stem cells: immunomodulatory properties and clinical application].Lijec Vjesn. 2012 Jan-Feb;134(1-2):42-9. Lijec Vjesn. 2012. PMID: 22519252 Review. Croatian.
Cited by
-
The impact of immune response on endochondral bone regeneration.NPJ Regen Med. 2018 Nov 29;3:22. doi: 10.1038/s41536-018-0060-5. eCollection 2018. NPJ Regen Med. 2018. PMID: 30510772 Free PMC article. Review.
-
Stem cell therapy for heart failure: Medical breakthrough, or dead end?World J Stem Cells. 2021 Apr 26;13(4):236-259. doi: 10.4252/wjsc.v13.i4.236. World J Stem Cells. 2021. PMID: 33959217 Free PMC article. Review.
-
Comparative Histological Study of Therapeutic Effect of Mesenchymal Stem Cells versus Mesenchymal Stem Cells Co-Cultured with Liver Tissue on Carbon Tetrachloride-Induced Hepatotoxicity in Adult Male Albino Rats.J Microsc Ultrastruct. 2022 Aug 18;11(4):225-236. doi: 10.4103/jmau.jmau_62_21. eCollection 2023 Oct-Dec. J Microsc Ultrastruct. 2022. PMID: 38213650 Free PMC article.
-
CTLA-4 Mediates Inhibitory Function of Mesenchymal Stem/Stromal Cells.Int J Mol Sci. 2018 Aug 7;19(8):2312. doi: 10.3390/ijms19082312. Int J Mol Sci. 2018. PMID: 30087255 Free PMC article.
-
The Role of Myofibroblasts in Physiological and Pathological Tissue Repair.Cold Spring Harb Perspect Biol. 2023 Jan 3;15(1):a041231. doi: 10.1101/cshperspect.a041231. Cold Spring Harb Perspect Biol. 2023. PMID: 36123034 Free PMC article. Review.
References
-
- Heyndrickx G. R., Baig H., Nellens P., Leusen I., Fishbein M. C., Vatner S. F. Depression of regional blood flow and wall thickening after brief coronary occlusions. The American Journal of Physiology. 1978;234(6):H653–H659. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources